Cargando…
Mitigating COVID-19 Mortality and Morbidity in China's Aging Population: A Focus on Available Medications and Future Developments
The COVID-19 pandemic, often referred to as the geropandemic, has put immense pressure on global healthcare systems worldwide, leading to a rush in the development and approval of medications for the treatment of the viral infection. Clinical trials on efficacy and safety had a limited spectrum on i...
Autor principal: | Bischof, Evelyne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676792/ https://www.ncbi.nlm.nih.gov/pubmed/37199593 http://dx.doi.org/10.14336/AD.2023.0318 |
Ejemplares similares
-
Basic and translational aging research in China: present and future
por: He, Xiaojuan, et al.
Publicado: (2019) -
Comprehensive Knowledge of Reservoir Hosts is Key to Mitigating Future Pandemics
por: Zhu, Pingfen, et al.
Publicado: (2020) -
Hepatitis E Vaccine to Prevent Morbidity and Mortality During Epidemics
por: Nelson, Kenrad E., et al.
Publicado: (2014) -
Availability and use of Standards in vaccine development
por: Avumegah, Michael Selorm, et al.
Publicado: (2023) -
Developmental Gerontology and Active Population Aging in China
por: Zheng, Xiaoying, et al.
Publicado: (2023)